Excellent post….. shows people that one drug that cant do 80% of what leronlimab can do nor can it do it with safety profile of Leronlimab was worth 21 billion. A much better drug much better safety it would be safe tovsay worth well more than 21+ billion. Thats why i keep buying and will not sell a single share because the bolagna $5 price predictions are way off base.